• Skip to primary navigation
  • Skip to main content
  • Skip to footer
  • Pessoal
    • Webmail
    • Área de Docentes
    • Área de Não-Docentes
  • Estudantes
    • Webmail
    • Moodle
    • NetP@
    • Biblioteca
    • Escola Doutoral
    • Serviços Académicos
    • Trabalhar no IHMT

IHMT

Instituto de Higiene e Medicina Tropical

  • O Instituto
    • Missão
    • História
    • Mensagem do Diretor
    • Órgãos de governo
    • Docentes e investigadores
    • Unidades de Ensino e de Investigação
  • Ensino
    • Doutoramentos
    • Mestrados
    • Cursos de Especialização
    • Formação transversal
    • Cursos de Curta Duração
    • Ensino à Distância
    • Apoio ao Desenvolvimento
    • Serviços académicos
  • Investigação
    • Centro GHTM
    • Unidade de Clínica Tropical
    • Unidade de Microbiologia Médica
    • Unidade de Parasitologia Médica
    • Unidade de Saúde Pública Global
    • Serviço de Interesse Comum
    • Biobanco
    • Centro Colaborador da OMS
    • Publicações
  • Serviços e gestão
    • Biblioteca
    • Sistema de Qualidade
    • Estatutos e regulamentos
    • Relatórios
    • Contratos públicos
    • Recursos humanos
      • Concursos e bolsas
      • Contratos
      • Avaliação e Desempenho
        • Processo Eleitoral da Comissão Paritária
      • Mobilidade
  • Doenças Tropicais
    • Consulta do Viajante
    • Glossário
    • Museu
    • Vídeos
    • MosquitoWeb
  • Comunidade
    • Cooperação e Desenvolvimento
    • Formação
    • Parcerias
  • Contactos
  • Português
  • English
Home / Archives for Matos O

Matos O

Portugal and Angola: similarities and differences in Toxoplasma gondii seroprevalence and risk factors among pregnant women

  • Autores: de Sousa B, Lobo M L, Matos O, Patrocinio G, Sevivas T
  • Ano de Publicação: 2016
  • Journal: Epidemiology and Infection
  • Link: https://www.ncbi.nlm.nih.gov/pubmed/27608967

In this study we determined the presence of IgM/IgG antibodies to Toxoplasma gondii in sera of 155 and 300 pregnant women from Lisbon (Portugal) and Luanda (Angola), respectively, and evaluated the potential risk factors associated with this infection.
Ler mais

ECIL guidelines for the diagnosis of Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients

  • Autores: Alanio A, Alanio A, Bretagne S, Bretagne S, Cesaro S, Cesaro S, Cordonnier C, Cordonnier C, Donnelly J P, Einsele H, Einsele H, Hauser P M, Hauser PM, Helweg-Larsen J, Helweg-Larsen J, Johan Maertens J, Lagrou K, Lagrou K, Maschmeyer G, Maschmeyer G, Matos O, Melchers W J G
  • Ano de Publicação: 2016
  • Journal: Journal of Antimicrobial Chemotherapy
  • Link: https://www.ncbi.nlm.nih.gov/pubmed/27550991

The Fifth European Conference on Infections in Leukaemia (ECIL-5) convened a meeting to establish evidence-based recommendations for using tests to diagnose Pneumocystis jirovecii pneumonia (PCP) in adult patients with haematological malignancies.
Ler mais

Study of the epidemiology of Pneumocystis carinii f. sp. suis in abattoir swine in Portugal

  • Autores: Antunes F, Esgalhado R, Esteves F, Matos O
  • Ano de Publicação: 2013
  • Journal: Medical Mycology
  • Link: http://www.ncbi.nlm.nih.gov/pubmed/22852751

Pneumocystis has been identified in various mammalian species, including domestic, wild and zoo animals. This study’s main objectives were: (1) to estimate the prevalence of the Pneumocystis carinii f. sp. suis infection in slaughtered pigs in Portugal, (2) assess the prevalence differences within distinct age groups of animals, (3) determine the possible associations between pulmonary lesions and the infection, and (4) genetically characterize the P. carinii f. sp. suis isolates recovered from infected animals using PCR with DNA sequencing.
Ler mais

Diagnosis of Pneumocystis pneumonia: evaluation of four serologic biomarkers

  • Autores: Antunes F, Badura R, CALDERÓN E. J., CALÉ S. S., DE BOER M. G., Esteves F, Maltez F, MARQUEZ-MARTIN E., Matos O, VAN DER REIJDEN T. J.
  • Ano de Publicação: 2015
  • Journal: Clinical microbiology and infection
  • Link: http://www.clinicalmicrobiologyandinfection.com/article/S1198-743X(14)00111-6/abstract

This study aimed to assess the usefulness of (1–3)-β-d-glucan (BG), Krebs von den Lungen-6 antigen (KL-6), lactate dehydrogenase (LDH) and S-adenosyl methionine (SAM) as serologic biomarkers in the diagnosis of PCP.
Ler mais

The 13th International Workshops on Opportunistic Protists (IWOP13)

  • Autores: CALDERÓN E. J., CUSHION M. T., KANESHIRO E. S., LORENZO-MORALES J., Matos O, WEISS L. M., Xiao L
  • Ano de Publicação: 2015
  • Journal: Journal of Eukaryotic Microbiology
  • Link: https://www.ncbi.nlm.nih.gov/pubmed/25923469

The 13th International Workshops on Opportunistic Protists (IWOP-13) was held November 13-15, 2014 in Seville, Spain. The objectives of the IWOP meetings are to: (1) serve as a forum for exchange of new information among active researchers concerning the basic biology, molecular genetics, immunology, biochemistry, pathogenesis, drug development, therapy, and epidemiology of these immunodeficiency-associated pathogenic eukaryotic microorganisms that are seen in patients with AIDS and; (2) to foster the entry of new and young investigators into these underserved research areas.
Ler mais

Microsporidia as emerging pathogens and the implication for public health: a 10-year study on HIV-positive and -negative patients.

  • Autores: Antunes F, Lobo ML, Matos O, Xiao L
  • Ano de Publicação: 2012
  • Journal: International Journal for Parasitology
  • Link: http://www.ncbi.nlm.nih.gov/pubmed/?term=Microsporidia+as+emerging+pathogens+and+the+implication+for+public+health%3A+A+10-year+study+on+HIV-positive+and+-negative+patients.

Despite recent advances in the understanding and diagnosis of emerging microsporidian pathogens, more research is necessary to elucidate their complex epidemiology. In fact, studies that reflect true human-infecting microsporidian prevalence are still inadequate. The present 10-year study was undertaken to examine the occurrence of Microsporidia in 1989 stools, 69 urine and 200 pulmonary specimens from HIV-positive and HIV-negative patients using PCR and DNA sequencing.
Ler mais

Pneumocystis jirovecii pneumonia: still a concern in patients with haematological malignancies and stem cell transplant recipients

  • Autores: a joint venture of The European Group for Blood and Marrow Transplantation (EBMT), Alanio A, Bretagne S, Cesaro S, Cordonnier C, Donnelly JP, Einsele H, Hauser PM, Helweg-Larsen J, Lagrou K, Maertens J; Fifth European Conference on Infections in Leukemia (ECIL-5), Maschmeyer G, Matos O, Melchers WJ, The European Organization for Research and Treatment of Cancer (EORTC), the Immunocompromised Host Society (ICHS) and The European LeukemiaNet (ELN)
  • Ano de Publicação: 2016
  • Journal: Journal of Antimicrobial Chemotherapy
  • Link: https://www.ncbi.nlm.nih.gov/pubmed/27550990

Pneumocystis jirovecii can cause life-threatening pneumonia following treatment for haematological malignancies or after HSCT. The mortality rate of P. jirovecii pneumonia (PCP) in these patients is 30%-60%, especially after HSCT. The clinical presentation of PCP in haematology differs from that associated with HIV infection, with the disease being acute and more often severe, having a lower fungal burden and being more frequently linked to treatment with corticosteroids.
Ler mais

Multicentre study highlighting clinical relevance of new high-throughput methodologies in molecular epidemiology of Pneumocystis jirovecii pneumonia

  • Autores: Antunes F, Badura R, BASSAT Q., CALDERÓN E. J., de Armas Y, de Sousa B, Esteves F, HUANG L., Maltez F, Matos O
  • Ano de Publicação: 2016
  • Journal: Clinical microbiology and infection
  • Link: https://www.ncbi.nlm.nih.gov/pubmed/27021425

Pneumocystis jirovecii causes severe interstitial pneumonia (PcP) in immunosuppressed patients. This multicentre study assessed the distribution frequencies of epidemiologically relevant genetic markers of P. jirovecii in different geographic populations from Portugal, the USA, Spain, Cuba and Mozambique, and the relationship between the molecular data and the geographical and clinical information, based on a multifactorial approach.
Ler mais

Cell phenotypic change due to Cryptosporidium parvum infection in immunocompetent mice

  • Autores: Borrego M, Codices V, de Sousa B, Lopes A, Martins C, Matos O, Novo C, Pinho M
  • Ano de Publicação: 2013
  • Journal: Acta Parasitologica
  • Link: http://link.springer.com/article/10.2478%2Fs11686-013-0113-2

Cryptosporidium parvum is an intracellular parasite causing enteritis which can become life-threatening in immunocompromised host. Immunoregulatory T cells play a central role in the regulatory network of the host. Here, we proposed to characterize the populations of immune cells during infection and reinfection with C. parvum. Four-week-old BALB/C mice were inoculated with oocysts of C. parvum at days 0 and 22.
Ler mais

Unusual coexistence of opportunistic lung infections in a human immunodeficiency virus positive patient suffering from persistent pneumocystis jirovecii pneumonia: A case report

  • Autores: Araújo C, Esteves F, Mansinho K, Matos O, Miranda AC, Ponces Bento D, Ventura F
  • Ano de Publicação: 2013
  • Journal: Revista Portuguesa de Pneumologia
  • Link: http://www.elsevier.pt/en/revistas/revista-portuguesa-pneumologia-320/artigo/unusual-coexistence-of-opportunistic-lung-infections-in-human-90205531

It is well-established that HIV patients are at high risk of opportunistic infections (OI), like the ones caused by Pneumocystis jirovecii, a worldwide pathogen implicated in interstitial pneumonia (PcP). We present a case of a newly diagnosed HIV-1 patient with multiple OI, including a persistent form of PcP, an invasive aspergillosis (IA), cytomegalovirus and Mycobacterium xenopi lung infection. We describe the combination of laboratorial screening, surgery and antimicrobial therapy which were crucial for patient recovery.
Ler mais

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to Next Page »

Footer

INSTITUTO DE HIGIENE E
MEDICINA TROPICAL
UNIVERSIDADE NOVA DE LISBOA
Rua da Junqueira, 100 1349-008 Lisboa
T +351 213 652 600
geral@ihmt.unl.pt

Consulta do Viajante e Medicina Tropical
T +351 213 652 630
T +351 213 652 690
T +351 91 182 37 48
T +351 91 182 44 67
medicina.viagens@ihmt.unl.pt

Ensino
Investigação
Medicina Tropical
Cooperação

Siga-nos

  • Facebook
  • LinkedIn
  • YouTube

Receber a “newsletter”

© Copyright 2023 IHMT-UNL Todos os Direitos Reservados.
  • Universidade Nova de Lisboa
  • Fundação para a Ciência e a Tecnologia

    Project UID/Multi/04413/2013